LTRN Price / Book | Lantern Pharma Inc.

Lantern Pharma Inc. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

Lantern Pharma Inc. price/book ratio for the quarter ending 2026-06-30 was -16.62, a 699.20% decline year-over-year.
Lantern Pharma Inc. price/book ratio for the quarter ending 2026-03-31 was 4.43, a 94.48% increase year-over-year.
Lantern Pharma Inc. price/book ratio for the quarter ending 2025-12-31 was 5.18, a 219.29% increase year-over-year.
Lantern Pharma Inc. price/book ratio for the quarter ending 2025-09-30 was 5.02, a 237.03% increase year-over-year.
Lantern Pharma Inc. price/book ratio for fiscal 2026 was -16.62.
Lantern Pharma Inc. price/book ratio for fiscal 2025 was 5.18, a 219.29% increase from fiscal 2024.
Lantern Pharma Inc. price/book ratio for fiscal 2024 was 1.62, a 44.76% increase from fiscal 2023.
Lantern Pharma Inc. price/book ratio for fiscal 2023 was 1.12, a 4.15% decline from fiscal 2022.

Available history: 2020-06-30 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	-16.62	$53.46M	-$3.22M
2026-03-31	4.43	$15.25M	$3.45M
2025-12-31	5.18	$33.88M	$6.53M
2025-09-30	5.02	$48.08M	$9.59M
2025-06-30	2.77	$34.73M	$12.52M
2025-03-31	2.28	$38.18M	$16.78M
2024-12-31	1.62	$34.4M	$21.19M
2024-09-30	1.49	$39.58M	$26.6M
2024-06-30	1.62	$50.24M	$30.93M
2024-03-31	2.65	$94.68M	$35.77M
2023-12-31	1.12	$45.89M	$40.91M
2023-09-30	0.82	$37.06M	$45.41M
2023-06-30	1.27	$61.3M	$48.26M
2023-03-31	1	$52.44M	$52.58M
2022-12-31	1.17	$65.58M	$56.04M
2022-09-30	0.88	$51.9M	$59.03M
2022-06-30	1.01	$61.84M	$61.08M
2022-03-31	1.19	$77.44M	$65.32M
2021-12-31	1.24	$88.49M	$71.57M
2021-09-30	1.65	$125.07M	$75.73M
2021-06-30	2.05	$163.29M	$79.61M
2021-03-31	2.48	$202.83M	$81.73M
2020-12-31	6.08	$119.75M	$19.7M
2020-09-30	5.43	$117.14M	$21.57M
2020-06-30	3.4	$78.96M	$23.23M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	-16.62	$53.46M	-$3.22M
2025-12-31	5.18	$33.88M	$6.53M
2024-12-31	1.62	$34.4M	$21.19M
2023-12-31	1.12	$45.89M	$40.91M
2022-12-31	1.17	$65.58M	$56.04M
2021-12-31	1.24	$88.49M	$71.57M
2020-12-31	6.08	$119.75M	$19.7M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Citius Pharmaceuticals, Inc. (CTXR)	United States	$0.016B	-133.06
Anebulo Pharmaceuticals, Inc. (ANEB)	United States	$0.015B
Korsana Biosciences, Inc. (CYCN)	United States	$0.016B
ACTUATE THERAPEUTICS, INC. (ACTU)	United States	$0.015B
Tvardi Therapeutics, Inc. (TVRD)	United States	$0.014B
Vyome Holdings, Inc (HIND)	United States	$0.014B	-1.38
BullFrog AI Holdings, Inc. (BFRG)	United States	$0.014B
Pasithea Therapeutics Corp. (KTTA)	United States	$0.017B	-0.81
Allarity Therapeutics, Inc. (ALLR)	United States	$0.017B	-1.66
LISATA THERAPEUTICS, INC. (LSTA)	United States	$0.014B	-2.13